Physiologic Predictors of Respiratory Failure in Patients Presenting with Dyspnea
呼吸困难患者呼吸衰竭的生理预测因素
基本信息
- 批准号:10606999
- 负责人:
- 金额:$ 8.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAcute Respiratory Distress SyndromeAddressAirAlveolarAnimal ExperimentsBrainBreathingCOVID-19 pandemicCOVID-19 patientCannulasClinicalCohort StudiesCritical IllnessDataDeteriorationDevicesDyspneaEquipmentGasesHospitalizationImpairmentIndividualInjectionsInterventionIntubationLaboratoriesLife Support SystemsLiteratureLongitudinal StudiesLungLung diseasesMeasurementMechanical ventilationMechanicsMedicalNoseOutcomeOxygenOxygen Therapy CarePathogenesisPathologyPatient TriagePatientsPhysiologicalPhysiologyPredictive ValueProbabilityProductivityPrognosisRandomized, Controlled TrialsResearch DesignRespiratory FailureRespiratory MusclesRespiratory physiologyRiskSARS-CoV-2 infectionSalicylic AcidsShortness of BreathStressStructure of parenchyma of lungSymptomsTechniquesTestingTherapeuticTidal VolumeTractionTrainingVaccinesViral Respiratory Tract Infectioncareercisterna magnacohortexperiencehigh riskhuman datain vivolung injurylung pressuremetermillisecondmurine nodule inducing virusnovelpandemic diseasepoint of care testingpressurepreventprognosticationprogression riskrespiratorysupplemental oxygentheoriestoolventilation
项目摘要
Project Summary
Presentations of respiratory failure can vary from mild requiring supplemental oxygen to more severe
requiring invasive mechanical ventilation (i.e., acute respiratory distress syndrome or ARDS). Early in
respiratory failure patients often have abnormalities in gas exchange, control of breathing, and/or pulmonary
mechanics. During the ongoing COVID-19 pandemic, some studies have demonstrated that increased
respiratory drive is associated with worse clinical outcomes while others have demonstrated contrary findings.
We have also demonstrated that a noninvasive assessment of gas exchange using the alveolar gas meter
(AGM) is predictive of who will require supplemental oxygen from COVID-19 infection. Additional studies
predating the COVID-19 pandemic showed that increased inspiratory effort, large transpulmonary pressure
changes, and elevated dead space were all associated with worse outcomes in ARDS. However, many of
these studies focused on patients already intubated and mechanically ventilated. Less is known about the
relevance of these parameters in spontaneously breathing individuals. For a few years now the notion of
patient self-inflicted lung injury (P-SILI) has been gaining traction in the medical literature. The basic concept is
that patients with impending respiratory failure from existing lung injury can cause worsening damage to their
lungs. If patients are spontaneously breathing with excessively high respiratory drive, then they may generate
excessively negative inspiratory efforts leading to major transpulmonary pressure changes. The results of
these abnormalities are large tidal volumes like mechanically ventilating someone with injurious tidal volumes
prior to the advent of low tidal volume ventilation (LTVV). Also, retrospective review of large cohort studies and
randomized controlled trials of ARDS patients have demonstrated that spontaneously breathing patients prior
to intubation often generated excessively large tidal volumes. Whether their subsequent lung injury was
entirely due to their underlying ARDS pathology or partially due to superimposed P-SILI is not known. If a
physiological signature of impending respiratory failure in spontaneously breathing individuals exists and it is
associated with elevated respiratory drive, steps can subsequently be taken to mitigate the increased drive and
study the longitudinal effects of these variables in patients who develop respiratory failure. Moreover, if such a
signature exists and intervention abrogates some of the subsequent lung injury, this is a strong proof of
concept for P-SILI in vivo. We aim to test three independent but related hypotheses. First, the AGM is a novel
and simple technique which can be used to identify patients at increased risk for respiratory failure better than
traditional metrics. Second, the breath hold maneuver is a validated technique to assess control of breathing
that can identify patients with poor respiratory prognosis. Third, the airway occlusion pressure will provide
additional predictive value in identifying high risk patients. This proposal will lay the groundwork for the PI to
gain experience and training for a long and productive academic medical career.
项目摘要
呼吸衰竭的表现可以从需要补充氧气的轻度到更严重
需要有创机械通气(即,急性呼吸窘迫综合征或ARDS)。年初
呼吸衰竭患者通常具有气体交换、呼吸控制和/或肺功能的异常。
力学在持续的COVID-19大流行期间,一些研究表明,
呼吸驱动与更差的临床结果相关,而其他研究则证明了相反的结果。
我们还证明了使用肺泡气体测量仪进行气体交换的非侵入性评估
(AGM)可以预测谁将因COVID-19感染而需要补充氧气。其他研究
在COVID-19大流行之前的研究表明,
变化和死腔升高均与ARDS的不良结局相关。但许多
这些研究集中于已经插管和机械通气的患者。关于这一点,我们所知甚少。
这些参数在自主呼吸个体中的相关性。几年来,
患者自身造成的肺损伤(P-SILI)在医学文献中得到了越来越多的关注。基本概念是
由于现有肺损伤而即将发生呼吸衰竭的患者可能会导致其
肺如果患者自主呼吸,呼吸驱动过高,
过度的负吸气努力导致主要的经尿道压力变化。的结果
这些异常是大的潮气量,如机械通气的人与伤害潮气量
在低潮气量通气(LTVV)出现之前。此外,回顾性审查大型队列研究,
对ARDS患者的随机对照试验表明,
插管往往产生过大的潮气量。他们随后的肺损伤是否
完全由于其潜在的ARDS病理或部分由于叠加的P-SILI尚不清楚。如果
存在自发呼吸个体中即将发生呼吸衰竭的生理特征,
与升高的呼吸驱动相关,随后可以采取步骤来减轻增加的驱动,
研究这些变量在发生呼吸衰竭的患者中的纵向影响。此外,如果这样的
签名存在,干预消除了一些随后的肺损伤,这是一个强有力的证据,
体内P-SILI的概念。我们的目标是测试三个独立但相关的假设。首先,年度股东大会是一部小说
和简单的技术,可用于确定患者在呼吸衰竭的风险增加,
传统的度量。其次,屏气动作是一种有效的技术,以评估控制呼吸
可以识别出呼吸道预后不良的患者。第三,气道阻塞压力将提供
在识别高风险患者方面具有额外的预测价值。该提案将为PI奠定基础,
获得经验和培训,为长期和富有成效的学术医疗生涯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Cameron McGuire其他文献
William Cameron McGuire的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 8.33万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 8.33万 - 项目类别: